$2.10
7.14%
Nasdaq, Fri, Sep 18 2026.
ISIN
US7611234052
Symbol
RSLS

ReShape Lifesciences, Inc. Stock price

$2.10
-0.17 7.48% 1M
+0.02 0.96% 6M
-1.34 38.95% YTD
-4.51 68.23% 1Y
-4,005.70 99.95% 3Y
-843,897.90 100.00% 5Y
-2,483,709.90 100.00% 10Y
-746,171,997.90 100.00% 20Y
Nasdaq, Closing price Fri, Sep 18 2026
+0.14 7.14%

Is ReShape Lifesciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$2.5m
Shares outstanding
130.0k
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
-5.3%
Return on Equity
2,818.2%
ROCE
-266.8%
ROIC
-623.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$7.2m | $12.2m
EBITDA
$-6.3m
EBIT
$-6.3m
Net Income
$-3.5m
Free Cash Flow
$-4.5m
Growth (TTM | estimate)
Revenue
-13.9% | 52.7%
EBITDA
47.0%
EBIT
47.4%
Net Income
68.3%
Free Cash Flow
68.1%
Margin
Gross
63.7%
EBITDA
-87.5%
EBIT
-87.8%
Net
-48.3%
Free Cash Flow
-62.4%
More
EPS
$-178.3
FCF per Share
$-34.4
Short interest
2.2%
Employees
18
Rev per Employee
$450.0k

ReShape Lifesciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a ReShape Lifesciences, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a ReShape Lifesciences, Inc. forecast:

Hold
50%
Sell
50%

Financial data from ReShape Lifesciences, Inc.

Mar '25
+/-
%
7.18 7.18
14% 14%
100%
- Direct Costs 2.60 2.60
9% 9%
36%
4.57 4.57
17% 17%
64%
- Selling and Administrative Expenses 9.19 9.19
36% 36%
128%
- Research and Development Expense 1.68 1.68
28% 28%
23%
-6.28 -6.28
47% 47%
-87%
- Depreciation and Amortization 0.02 0.02
82% 82%
0%
EBIT (Operating Income) EBIT -6.30 -6.30
47% 47%
-88%
Net Profit -3.46 -3.46
68% 68%
-48%

In millions USD.

Don't miss a Thing! We will send you all news about ReShape Lifesciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ReShape Lifesciences Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded on December 2002 and is headquartered in San Clemente, CA.

Head office United States
CEO Mr. Hickey
Employees 18
Founded 2002
Website www.reshapelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today